V. Craig Jordan
Northwestern University
Chicago
USA
Name/email consistency: high
- Selective estrogen receptor modulation: concept and consequences in cancer. Jordan, V.C. Cancer. Cell (2004)
- Tamoxifen: a most unlikely pioneering medicine. Jordan, V.C. Nat. Rev. Drug. Discov (2003)
- Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy. Jordan, V.C., Ponder, B.A. Breast Cancer Res. (2003)
- Changing role of the oestrogen receptor in the life and death of breast cancer cells. Jordan, V.C., Osipo, C., Schafer, J.M., Fox, J.E., Cheng, D., Liu, H. Breast (2003)
- The secrets of selective estrogen receptor modulation: cell-specific coregulation. Jordan, V.C. Cancer. Cell (2002)
- A new day dawns: women without oestrogen or is a balance best?. Jordan, V.C. Breast Cancer Res. (2002)
- Selective estrogen receptor modulation: a personal perspective. Jordan, V.C. Cancer Res. (2001)
- Molecular classification of estrogens. Jordan, V.C., Schafer, J.M., Levenson, A.S., Liu, H., Pease, K.M., Simons, L.A., Zapf, J.W. Cancer Res. (2001)
- The past, present, and future of selective estrogen receptor modulation. Jordan, V.C. Ann. N. Y. Acad. Sci. (2001)
- Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture. Jordan, V.C. Ann. N. Y. Acad. Sci. (2001)
- Tamoxifen: a personal retrospective. Jordan, V.C. Lancet Oncol. (2000)